Cargando…

Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study

BACKGROUND: Nodding syndrome is an epidemic symptomatic generalized epilepsy syndrome of unknown cause in Eastern Africa. Some patients have extreme short stature. We hypothesized that growth failure in nodding syndrome is associated with specific endocrine dysfunctions. In this pilot study, we exam...

Descripción completa

Detalles Bibliográficos
Autores principales: Piloya-Were, Theresa, Odongkara-Mpora, Beatrice, Namusoke, Hanifa, Idro, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289198/
https://www.ncbi.nlm.nih.gov/pubmed/25430904
http://dx.doi.org/10.1186/1756-0500-7-858
_version_ 1782352063907233792
author Piloya-Were, Theresa
Odongkara-Mpora, Beatrice
Namusoke, Hanifa
Idro, Richard
author_facet Piloya-Were, Theresa
Odongkara-Mpora, Beatrice
Namusoke, Hanifa
Idro, Richard
author_sort Piloya-Were, Theresa
collection PubMed
description BACKGROUND: Nodding syndrome is an epidemic symptomatic generalized epilepsy syndrome of unknown cause in Eastern Africa. Some patients have extreme short stature. We hypothesized that growth failure in nodding syndrome is associated with specific endocrine dysfunctions. In this pilot study, we examined the relationship between serum hormone levels and stature, bone age and sexual development. RESULTS: We recruited ten consecutive children, 13 years or older, with World Health Organization defined nodding syndrome and assessed physical growth, bone age, development of secondary sexual characteristics and serum hormone levels. Two children with incomplete results were excluded. Of the eight remaining, two had severe stunting (height for age Z [HAZ] score < -3) and three had moderate stunting (HAZ score between-3 and -2). The bone age was delayed by a median 3(range 0-4) years. Serum growth hormone levels were normal in all eight but the two patients with severe stunting and one with moderate stunting had low levels of Somatomedin C (Insulin like Growth Factor [IGF1]) and/or IGF binding protein 3 (IGFBP3), mediators of growth hormone function. A linear relationship was observed between serum IGF1 level and HAZ score. With the exception of one child, all were either pre-pubertal or in early puberty (Tanner stages 1 and 2) and in the seven, levels of the gonadotrophins (luteinising and follicle stimulating hormone) and the sex hormones (testosterone/oestrogen) were all within pre-pubertal ranges or ranges of early puberty. Thyroid function, prolactin, adrenal, and parathyroid hormone levels were all normal. CONCLUSIONS: Patients with nodding syndrome may have dysfunctions in the pituitary growth hormone and pituitary gonadal axes that manifest as stunted growth, delayed bone age and puberty. Studies are required to determine if such endocrine dysfunction is a primary manifestation of the disease or a secondary consequence of chronic ill health and malnutrition and if so, whether targeted interventions can improve outcome.
format Online
Article
Text
id pubmed-4289198
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42891982015-01-11 Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study Piloya-Were, Theresa Odongkara-Mpora, Beatrice Namusoke, Hanifa Idro, Richard BMC Res Notes Research Article BACKGROUND: Nodding syndrome is an epidemic symptomatic generalized epilepsy syndrome of unknown cause in Eastern Africa. Some patients have extreme short stature. We hypothesized that growth failure in nodding syndrome is associated with specific endocrine dysfunctions. In this pilot study, we examined the relationship between serum hormone levels and stature, bone age and sexual development. RESULTS: We recruited ten consecutive children, 13 years or older, with World Health Organization defined nodding syndrome and assessed physical growth, bone age, development of secondary sexual characteristics and serum hormone levels. Two children with incomplete results were excluded. Of the eight remaining, two had severe stunting (height for age Z [HAZ] score < -3) and three had moderate stunting (HAZ score between-3 and -2). The bone age was delayed by a median 3(range 0-4) years. Serum growth hormone levels were normal in all eight but the two patients with severe stunting and one with moderate stunting had low levels of Somatomedin C (Insulin like Growth Factor [IGF1]) and/or IGF binding protein 3 (IGFBP3), mediators of growth hormone function. A linear relationship was observed between serum IGF1 level and HAZ score. With the exception of one child, all were either pre-pubertal or in early puberty (Tanner stages 1 and 2) and in the seven, levels of the gonadotrophins (luteinising and follicle stimulating hormone) and the sex hormones (testosterone/oestrogen) were all within pre-pubertal ranges or ranges of early puberty. Thyroid function, prolactin, adrenal, and parathyroid hormone levels were all normal. CONCLUSIONS: Patients with nodding syndrome may have dysfunctions in the pituitary growth hormone and pituitary gonadal axes that manifest as stunted growth, delayed bone age and puberty. Studies are required to determine if such endocrine dysfunction is a primary manifestation of the disease or a secondary consequence of chronic ill health and malnutrition and if so, whether targeted interventions can improve outcome. BioMed Central 2014-11-28 /pmc/articles/PMC4289198/ /pubmed/25430904 http://dx.doi.org/10.1186/1756-0500-7-858 Text en © Piloya-Were et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Piloya-Were, Theresa
Odongkara-Mpora, Beatrice
Namusoke, Hanifa
Idro, Richard
Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study
title Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study
title_full Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study
title_fullStr Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study
title_full_unstemmed Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study
title_short Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study
title_sort physical growth, puberty and hormones in adolescents with nodding syndrome; a pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289198/
https://www.ncbi.nlm.nih.gov/pubmed/25430904
http://dx.doi.org/10.1186/1756-0500-7-858
work_keys_str_mv AT piloyaweretheresa physicalgrowthpubertyandhormonesinadolescentswithnoddingsyndromeapilotstudy
AT odongkaramporabeatrice physicalgrowthpubertyandhormonesinadolescentswithnoddingsyndromeapilotstudy
AT namusokehanifa physicalgrowthpubertyandhormonesinadolescentswithnoddingsyndromeapilotstudy
AT idrorichard physicalgrowthpubertyandhormonesinadolescentswithnoddingsyndromeapilotstudy